Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s Basic Consolidated EPS Came In At $-5.2884

0

The annual basic consolidated EPS for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) posted annual basic consolidated EPS of $-5.2884 for the year period ended2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-5.2884.

What About EPS from continuing operations

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s EPS from continuing operations for the annual period ended 2015-12-31 came in at -5.4022. On quarterly basis, EPS from continuing operations stood at $-5.4022 for the three-month period ended 2015-12-31.

EPS contribution from parent

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) received of $-5.2884 EPS boost from the parent company for the annual period ended 2015-12-31. For the quarter period ended 2015-12-31, the company received EPS boost of $-5.2884 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-12-31 was$-5.4022, but for the quarter period ended 2015-12-31 the basic net EPS was $-5.4022.

What About Consolidated Diluted EPS?

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) posted consolidated diluted EPS of $-5.2884 for the annual period ended 2015-12-31. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-12-31 stood at $-5.2884.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $-5.4022 for the annual period ended 2015-12-31. On quarter basis, diluted EPS from continuing operations was $-5.4022 for the three-month period ended 2015-12-31.

Net diluted EPS

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) posted net diluted EPS of $-5.4022for the annual period ended 2015-12-31. On the other hand, it posted net diluted EPS of $-5.4022 for thequarterly period ended 2015-12-31.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) contributed diluted EPS of $-5.2884. The diluted EPS contribution from the parent for the quarter ended 2015-12-31 stood at $-5.2884.

The company’s net basic EPS for the annual period ended 2015-12-31 was $-64.8519 while for the quarter period ended 2015-12-31 it was $-64.8519.

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) had average basic shares outstanding of 0.2259 for the annual period ended 2015-12-31 and 0.2259 for the quarter period ended 2015-12-31.The number of diluted shares outstanding was 0.2259 for the annual period ended 2015-12-31 and 0.2259 for the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 21 times, 1 visits today)